How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

18,184 results for

"grant funding" or "obtaining grants" or "getting grants" or "grant awards" or (grants and "how to")

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

17761. Belatacept Post Depletional Repopulation to Facilitate Tolerance

automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number): Layout table for additonal information Responsible Party: Antonio Guasch, M.D., Professor, Emory University ClinicalTrials.gov Identifier: Other Study ID Numbers: IRB00005064 Grant # FD-R-003539 ( Other Grant/Funding Number: FDA Office of Orphan Products ) eIRB 00005064 ( Other Identifier: Emory University Institutional Review Board ) BMS IM103-036 ( Other Identifier: Other ) First Posted: November 30, 2007 Last Update Posted

2007 Clinical Trials

17762. Seprafilm® Adhesion Barrier and Cesarean Delivery

to Layout table for additonal information Responsible Party: Daniel Kiefer, Principal Investigator, Winthrop University Hospital ClinicalTrials.gov Identifier: Other Study ID Numbers: IRB No. 07023 MO1RR10710 ( Other Grant/Funding Number: General Clinical Research Center (GCRC) ) First Posted: November 30, 2007 Results First Posted: April 22, 2016 Last Update Posted: April 22, 2016 Last Verified: March 2016 Individual Participant Data (IPD) Sharing Statement: Plan to Share IPD: No Keywords provided

2007 Clinical Trials

17763. Radiation Therapy and Androgen Deprivation Therapy in Treating Patients Who Have Undergone Surgery for Prostate Cancer (RADICALS)

: Other Study ID Numbers: CDR0000571528 MRC-RADICALS-PR10 ISRCTN40814031 EUDRACT-2006-000205-34 EU-20767 PR13 PR13 ( Other Grant/Funding Number: Canadian Cancer Society - Research Institute ) First Posted: October 8, 2007 Last Update Posted: October 13, 2017 Last Verified: October 2017 Keywords provided by Medical Research Council: sexual dysfunction urinary complications gastrointestinal complications adenocarcinoma of the prostate stage I prostate cancer stage IIB prostate cancer stage IIA prostate (...) , or bicalutamide, may lessen the amount of androgens made by the body. Giving radiation therapy together with androgen deprivation therapy may kill more prostate cancer cells. PURPOSE: This randomized phase III trial is studying how well giving radiation therapy together with androgen deprivation therapy works in treating patients who have undergone surgery for prostate cancer. Condition or disease Intervention/treatment Phase Gastrointestinal Complications Prostate Cancer Sexual Dysfunction Urinary

2007 Clinical Trials

17764. Effect of Genistein in Women With Metabolic Syndrome

Principal Investigator: Rosario D'Anna, professor University of Messina, Italy Principal Investigator: Francesco Squadrito, MD University of Messina More Information Go to Publications: Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number): Layout table for additonal information Responsible Party: Rosario D'anna, Associate Professor, University of Messina ClinicalTrials.gov Identifier: Other Study ID Numbers: RODA-12254 20073XZSR3 ( Other Grant/Funding Number

2007 Clinical Trials

17765. Depression Treatment and Screening in Ovarian Cancer Patients

information Principal Investigator: Eileen H. Shinn, PhD M.D. Anderson Cancer Center More Information Go to Additional Information: Layout table for additonal information Responsible Party: M.D. Anderson Cancer Center ClinicalTrials.gov Identifier: Other Study ID Numbers: ID02-258 NCI-2012-02127 ( Registry Identifier: NCI CTRP ) 1CF2002-0000832 HM 01 ( Other Grant/Funding Number: Lance Armstrong Foundation ) First Posted: August 13, 2007 Last Update Posted: January 24, 2018 Last Verified: January 2018

2007 Clinical Trials

17766. Vaccine Therapy in Treating Patients With Stage D0 Prostate Cancer

: Kael-GemVax Co., Ltd. Collaborator: National Cancer Institute (NCI) Information provided by (Responsible Party): Kael-GemVax Co., Ltd. Study Details Study Description Go to Brief Summary: RATIONALE: Vaccines made from tumor cells may help the body build an effective immune response to kill tumor cells. PURPOSE: This randomized phase II trial is studying vaccine therapy to see how well it works compared with a placebo in treating patients with stage D0 prostate cancer. Condition or disease (...) -related immunotherapy Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00514072 Locations Layout table for location information United States, Maryland Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland

2007 Clinical Trials

17767. Transporter Mediated Uptake of Montelukast

Information Go to Additional Information: Publications: Layout table for additonal information Responsible Party: Ed Mougey, Reserach Scientist, Nemours Children's Clinic ClinicalTrials.gov Identifier: Other Study ID Numbers: 32711 32-03215-003 ( Other Grant/Funding Number: Nemours internal activity number ) First Posted: August 9, 2007 Last Update Posted: January 24, 2014 Last Verified: January 2014 Keywords provided by Ed Mougey, Nemours Children's Clinic: Pharmacogenetics Singulair montelukast (...) that Singulair requires these transporters to be efficiently absorbed. Eventually, what we learn from this work will allow doctors to quickly test individuals with asthma to determine how well they will absorb Singulair and possibly other LTRAs. Knowing this will allow the doctor to adjust the drug treatment on an individual basis to maximize benefit in the treatment of asthma. Condition or disease Intervention/treatment Phase Asthma Dietary Supplement: Grapefruit juice Dietary Supplement: Orange Juice

2007 Clinical Trials

17768. S-Adenosyl-L-Methionine Disulphate P-Toluene-Sulfonate in Preventing Liver Cancer in Patients With Chronic Hepatitis C Infection

information Principal Investigator: John Hoefs Chao Family Comprehensive Cancer Center More Information Go to Publications of Results: Layout table for additonal information Responsible Party: Chao Family Comprehensive Cancer Center, Cancer Center, University of California, Irvine ClinicalTrials.gov Identifier: Other Study ID Numbers: UCI 06-07 / NCI-2009-00897 CDR0000558657 ( Registry Identifier: PDQ (Physician Data Query) ) UCI04-3-01 ( Other Grant/Funding Number: NCI ) First Posted: August 8, 2007 (...) 10, 2018 Sponsor: Chao Family Comprehensive Cancer Center Collaborator: National Cancer Institute (NCI) Information provided by (Responsible Party): Chao Family Comprehensive Cancer Center, University of California, Irvine Study Details Study Description Go to Brief Summary: This randomized phase II trial studies how well S-Adenosyl-L-Methionine Disulphate P-Toluene-Sulfonate (SAMe) works compared to a placebo in preventing liver cancer in patients with chronic hepatitis C infection

2007 Clinical Trials

17769. The Long-term Evaluation of Glucosamine Sulphate Study

and Joint Research, University of Sydney More Information Go to Additional Information: Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number): Layout table for additonal information Responsible Party: Dr Marlene Fransen, University of Sydney ClinicalTrials.gov Identifier: Other Study ID Numbers: GI-IM-LEGS-L NHMRC 402511 ( Other Grant/Funding Number: National Health and Medical Research Council of Australia ) NHMRC 402781 ( Other Grant/Funding Number: National

2007 Clinical Trials

17770. Observational Study of HIV Infected Women Previously Enrolled in Other Microbicide Trials

Layout table for investigator information Study Chair: Sharon A. Riddler, MD University of Pittsburgh More Information Go to Additional Information: Publications: Layout table for additonal information Responsible Party: Microbicide Trials Network ClinicalTrials.gov Identifier: Other Study ID Numbers: MTN-015 10529 ( Other Grant/Funding Number: DAIDS Protocol ID ) First Posted: August 9, 2007 Last Update Posted: February 25, 2019 Last Verified: February 2019 Keywords provided by Microbicide Trials

2007 Clinical Trials

17771. The Role of Macular Pigment in Patients With Age-related Macular Degeneration

Hospital Inselspital, Berne ClinicalTrials.gov Identifier: Other Study ID Numbers: KEK 73/05 SNF 3200 Bo-109962/1 ( Other Grant/Funding Number: SNF ) First Posted: June 29, 2007 Last Update Posted: May 3, 2018 Last Verified: May 2018 Keywords provided by Sebastian Wolf, University Hospital Inselspital, Berne: age related maculopathy, macular pigment Additional relevant MeSH terms: Layout table for MeSH terms Macular Degeneration Retinal Degeneration Retinal Diseases Eye Diseases

2007 Clinical Trials

17772. Management of Early Onset Neonatal Septicaemia: Selection of Optimal Antibacterial Regimen for Empiric Treatment

Update Posted : May 29, 2008 Sponsor: University of Tartu Collaborators: Estonian Science Foundation ESPID Small grant award Information provided by: University of Tartu Study Details Study Description Go to Brief Summary: A prospective two-center antibiotic regimen switch study will be conducted to compare the clinical efficacy of two antibiotic regimens - penicillin/gentamicin versus ampicillin/gentamicin - in the empirical treatment of early onset neonatal sepsis. The influence of either regimen (...) , Estonia Tartu University Clinics, Department of Paediatric Intensive Care Tartu, Estonia, 50411 Sponsors and Collaborators University of Tartu Estonian Science Foundation ESPID Small grant award Investigators Layout table for investigator information Study Chair: Irja Lutsar, MD, PhD University of Tartu More Information Go to Publications: Schrag S., Gorwitz R., Fultz-Butts K., Schuchat A., Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases. Prevention of Perinatal

2007 Clinical Trials

17773. Abatacept in ANCA Associated Vasculitis

for investigator information Study Director: Alan Salama Imperial College London More Information Go to Layout table for additonal information Responsible Party: Imperial College London ClinicalTrials.gov Identifier: Other Study ID Numbers: cro632 2006-001859-35 ( EudraCT Number ) BMS protocol No: IST110 ( Other Grant/Funding Number: Bristol Myers Squib funder ) First Posted: June 4, 2007 Last Update Posted: May 29, 2015 Last Verified: March 2015 Keywords provided by Imperial College London: Wegener's

2007 Clinical Trials

17774. Lenalidomide, Sunitinib, and Cyclophosphamide in Treating Patients With Stage IV Eye Melanoma

needed for cell growth. Drugs used in chemotherapy, such as cyclophosphamide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving lenalidomide together with sunitinib and low doses of cyclophosphamide once a day may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving lenalidomide together with sunitinib and cyclophosphamide works in treating patients with stage IV eye melanoma. Condition or disease (...) and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00482911 Locations Layout table for location information United States, Maryland Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 Sponsors

2007 Clinical Trials

17775. Long-Term Olanzapine Treatment in Children With Autism

Investigator: Richard P. Malone, MD Drexel University College of Medicine More Information Go to Layout table for additonal information Responsible Party: Drexel University ClinicalTrials.gov Identifier: Other Study ID Numbers: DDTR B2-NDA ( Other Grant/Funding Number: NIH ) First Posted: September 16, 2005 Last Update Posted: August 15, 2014 Last Verified: August 2014 Keywords provided by Drexel University: Drug Treatment Child Olanzapine Additional relevant MeSH terms: Layout table for MeSH terms

2005 Clinical Trials

17776. Stop Atherosclerosis in Native Diabetics Study

) and events such as heart attacks and strokes. The study will also look at secondary endpoints such as how well the heart pumps, fat,protein and inflammatory markers in the blood,and kidney function. The study enrolled 549 American Indian men and women with diabetes, > 40 years of age and is being conducted in four field centers involving Indian Health Service/Tribal primary care facilities in Phoenix/Sacaton, Arizona; Chinle, Arizona; Rapid City/Pine Ridge, South Dakota; and Lawton, Oklahoma, with input (...) Information Go to Layout table for additonal information ClinicalTrials.gov Identifier: Other Study ID Numbers: 2000-285 Grant # 1 U01 HL67031 First Posted: September 7, 2005 Last Update Posted: November 1, 2006 Last Verified: September 2005 Keywords provided by Medstar Health Research Institute: lowering LDL and BP below current targets LDL cholesterol treatment blood pressure treatment carotid intimal medial thickness prevent progression of CVD Additional relevant MeSH terms: Layout table for MeSH terms

2005 Clinical Trials

17777. Kaletra Sex/Gender Pharmacokinetics (PK) Study

of Medicine, Emory University ClinicalTrials.gov Identifier: Other Study ID Numbers: IRB00002448 UPN 04092824 ( Other Grant/Funding Number: Abbott Virology ) GCRC0605G ( Other Identifier: Other ) First Posted: September 8, 2005 Results First Posted: October 22, 2013 Last Update Posted: December 3, 2013 Last Verified: November 2013 Keywords provided by Ighovwerha Ofotokun, Emory University: Sex differences Pharmacokinetic Lopinavir/ritonavir Treatment Experienced HIV-infection Additional relevant MeSH

2005 Clinical Trials

17778. CHIZAP: Community- and Health Facility-Based Intervention With Zinc as Adjuvant Therapy for Childhood Pneumonia

Department of Epidemiology Research, Statens Serum Institut, 2300 Copenhagen S, Denmark More Information Go to Publications: Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number): Layout table for additonal information Responsible Party: Tor A. Strand, Professor, Centre For International Health ClinicalTrials.gov Identifier: Other Study ID Numbers: 003740 003740(Eur. Comm. INCO) ( Other Grant/Funding Number: European Union ) NUFU PRO 36/2002 ( Other Grant/Funding

2005 Clinical Trials

17779. Systematic Care for Informal Caregivers of Dementia Patients: An Efficient Approach?

often remain invisible until a crisis occurs. This inhibition is partly the result of informal caregivers paying scant attention to their own problems. Another reason is that professionals may not know how to support informal caregivers pro-actively (Van Hout et al., 2000). Therefore the family support programme (Bengtson, 1985: Vernooij et al., 2000) has been transformed into a Systematic Care Programme (SCP-Dementia). The reasons for choosing and studying the efficiency of this programme (...) (psychologists and social psychiatric nurses) will be randomly assigned to either the intervention group or the control group before the recruitment of patients and informal caregivers. The study population consists of pairs of patients and their informal caregivers visiting the ambulatory mental health care service for the first time. The intervention is the training in SCP-Dementia and its subsequent use. SCP-Dementia consists of an assessment of the caregiver's sense of competence and suggestions on how

2005 Clinical Trials

17780. 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis

Clinical Center (CC) Collaborator: National Cancer Institute (NCI) Information provided by: National Institutes of Health Clinical Center (CC) Study Details Study Description Go to Brief Summary: RATIONALE: Drugs used in chemotherapy, such as 17-N-allylamino-17-demethoxygeldanamycin (17-AAG), work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well 17-AAG works in treating patients (...) therapy NOTE: *Unless approved by the investigator Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00132015 Locations Layout table for location information United States, Maryland Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral

2005 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>